For his role in fomenting the opioid crisis, federal officials want to sentence Insys Therapeutics founder John Kapoor to 15 years in prison. His lawyers, however, argue the former high-flying executive should be locked away for just one year and a day, then confined to his home and perform community service.

The contrasting views toward his fate were explained in detail in sentencing documents filed this week in federal court, where Kapoor and several other former Insys executives earlier this year were convicted of wire and mail fraud in connection with a scheme to illegally boost prescriptions for the Subsys painkiller, which contains fentanyl, a powerful and addictive opioid.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy